Literature DB >> 29748374

The miR-371∼373 Cluster Represses Colon Cancer Initiation and Metastatic Colonization by Inhibiting the TGFBR2/ID1 Signaling Axis.

Pit Ullmann1, Fabien Rodriguez1, Martine Schmitz1, Steffen K Meurer2, Komal Qureshi-Baig1, Paul Felten1, Aurélien Ginolhac3, Laurent Antunes4, Sonia Frasquilho4, Nikolaus Zügel5, Ralf Weiskirchen2, Serge Haan1, Elisabeth Letellier6.   

Abstract

The vast majority of colorectal cancer-related deaths can be attributed to metastatic spreading of the disease. Therefore, deciphering molecular mechanisms of metastatic dissemination is a key prerequisite to improve future treatment options. With this aim, we took advantage of different colorectal cancer cell lines and recently established primary cultures enriched in colon cancer stem cells, also known as tumor-initiating cells (TIC), to identify genes and miRNAs with regulatory functions in colorectal cancer progression. We show here that metastasis-derived TICs display increased capacity for self-renewal, TGFβ signaling activity, and reduced expression of the miR-371∼373 cluster compared with nonmetastatic cultures. TGFβ receptor 2 (TGFBR2) and aldehyde dehydrogenase A1 (ALDH1A1) were identified as important target genes of the miR-371∼373 cluster. In addition, TGFBR2 repression, either by direct knockdown or indirectly via overexpression of the entire miR-371∼373 cluster, decreased tumor-initiating potential of TICs. We observed significantly reduced in vitro self-renewal activity as well as lowered tumor initiation and metastatic outgrowth capacity in vivo following stable overexpression of the miR-371∼373 cluster in different colon TIC cultures. Inhibitor of DNA binding 1 (ID1) was affected by both TGFBR2 and miR-371∼373 cluster alterations. Functional sphere and tumor formation as well as metastatic dissemination assays validated the link between miR-371∼373 and ID1. Altogether, our results establish the miR-371∼373/TGFBR2/ID1 signaling axis as a novel regulatory mechanism of TIC self-renewal and metastatic colonization.Significance: These findings establish the miR-371∼373/TGFBR2/ID1 signaling axis as a novel mechanism regulating self-renewal of tumor-initiating cell and metastatic colonization, potentially opening new concepts for therapeutic targeting of cancer metastasis.Graphical Abstract: http://cancerres.aacrjournals.org/content/canres/78/14/3793/F1.large.jpg Cancer Res; 78(14); 3793-808. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29748374     DOI: 10.1158/0008-5472.CAN-17-3003

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  MiR-106a-5p promotes 5-FU resistance and the metastasis of colorectal cancer by targeting TGFβR2.

Authors:  Jian Liu; Yanqin Huang; Hongqian Wang; Denghai Wu
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

2.  The E3 ligase HUWE1 mediates TGFBR2 ubiquitination and promotes gastric cancer cell proliferation, migration, and invasion.

Authors:  Yuting He; Jianming Zhou; Qinsi Wan
Journal:  Invest New Drugs       Date:  2021-01-06       Impact factor: 3.850

3.  LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis.

Authors:  Hongchao Xu; Beilin Zhang; Yinggui Yang; Zihuang Li; Pan Zhao; Weiqing Wu; Huirong Zhang; Jie Mao
Journal:  J Cell Mol Med       Date:  2020-04-22       Impact factor: 5.310

4.  TGF-βRII Knock-down in Pancreatic Cancer Cells Promotes Tumor Growth and Gemcitabine Resistance. Importance of STAT3 Phosphorylation on S727.

Authors:  Vincent Drubay; Nicolas Skrypek; Lucie Cordiez; Romain Vasseur; Céline Schulz; Nihad Boukrout; Belinda Duchêne; Lucie Coppin; Isabelle Van Seuningen; Nicolas Jonckheere
Journal:  Cancers (Basel)       Date:  2018-07-31       Impact factor: 6.639

5.  miR-516a-3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway.

Authors:  Yanyan Chi; Feng Wang; Tengfei Zhang; Han Xu; Yana Zhang; Zhengzheng Shan; Shaoxuan Wu; Qingxia Fan; Yan Sun
Journal:  J Cell Mol Med       Date:  2019-07-05       Impact factor: 5.310

6.  A long noncoding RNA cluster-based genomic locus maintains proper development and visual function.

Authors:  Fei Wang; Dalong Ren; Xiaolin Liang; Shengwei Ke; Bowen Zhang; Bing Hu; Xiaoyuan Song; Xiangting Wang
Journal:  Nucleic Acids Res       Date:  2019-07-09       Impact factor: 16.971

7.  Exploring the Pharmacological Mechanism of the Herb Pair "HuangLian-GanJiang" against Colorectal Cancer Based on Network Pharmacology.

Authors:  Benjiao Gong; Yanlei Kao; Chenglin Zhang; Huishan Zhao; Fudong Sun; Zhaohua Gong
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-29       Impact factor: 2.629

Review 8.  Inhibitor of Differentiation 1 (Id1) in Cancer and Cancer Therapy.

Authors:  Zhengxiao Zhao; Zhiyuan Bo; Weiyi Gong; Yong Guo
Journal:  Int J Med Sci       Date:  2020-04-06       Impact factor: 3.738

Review 9.  MicroRNA Involvement in Signaling Pathways During Viral Infection.

Authors:  Madalina Gabriela Barbu; Carmen Elena Condrat; Dana Claudia Thompson; Oana Larisa Bugnar; Dragos Cretoiu; Oana Daniela Toader; Nicolae Suciu; Silviu Cristian Voinea
Journal:  Front Cell Dev Biol       Date:  2020-03-10

10.  Propofol Inhibits Cell Proliferation, Migration, and Invasion via mir-410-3p/Transforming Growth Factor-β Receptor Type 2 (TGFBR2) Axis in Glioma.

Authors:  Fengli Li; Fengliang Li; Wei Chen
Journal:  Med Sci Monit       Date:  2020-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.